Study of a new pill for advanced blood cancers
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests a new pill for people with certain blood cancers that have not gotten better with standard treatments. It aims to see if the drug is safe and works, and it may help shrink tumors or slow the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a blood cancer, like B-cell lymphoma, acute lymphoblastic leukemia, or a myeloid cancer (such as AML), that has not responded to or has returned after standard treatments.
- You can still do most daily activities—either fully or with only light help—and your doctor expects you to live at least 3 more months.
- You agree to have bone marrow tests (aspiration or biopsy) as part of the study.
- You must not have certain other conditions like active infections (hepatitis B, C, or HIV), serious heart or lung disease, or another cancer in the last 5 years (except skin cancer or an early-stage cancer).
- You are not pregnant or breastfeeding, and if you can have children, you agree to use effective birth control during and after the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug, XS-04, for people with certain blood cancers (like B-cell lymphoma, AML, or MDS) that have come back or not responded to standard treatments. The goal is to see if the drug is safe and can help shrink tumors or control the disease.
This trial tests a new treatment for people with advanced blood cancers like leukemia or lymphoma that have come back or not improved. The goal is to see if the drug can help control the disease.
This trial tests an investigational pill (SHR2554) for people with follicular lymphoma that has come back or not responded to previous treatment. The goal is to see if the pill can shrink the lymphoma and help control the disease.
This trial tests an experimental drug called FXB0871 in people with advanced solid tumors that have stopped responding to standard treatments or for whom no standard treatment exists. The goal is to see if the drug is safe and effective, and patients who enroll will receive close monitoring throughout the study.
This trial is testing a new pill for people with intermediate or high-risk myelofibrosis, a type of bone marrow cancer. It aims to see if the drug can help manage the disease and offer a new treatment option for those who may have limited choices.
This study tests a new pill called HLX97 for people with advanced breast, prostate, or lung cancer that has not responded to standard treatments. The goal is to find the safest dose and see if it can help slow or shrink the tumor.
Hear when a new Lymphoma, B-Cell trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.